Sacituzumab tirumotecan | Interleukin Related interleukin-related.com

Product Name :
Sacituzumab tirumotecan

Search keywords :
CL2A

drugId :
null

Target Vo:
Tumor-associated calcium signal transducer 2

Target Vo Short Name :
Trop-2

Moa_Name:
Anti-Trop-2

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Klus Pharma Inc

Active Company_Name :
Klus Pharma Inc

Active Indication_Name:
Triple Negative Breast Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HSP70 Antibody (YA728)
FAK Antibody
RBPJK Antibody: RBPJK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to RBPJK. It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts